Publications by authors named "Alison Merrick"

Claim this Profile
C
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients.
Robert A Adair, Victoria Roulstone, Karen J Scott, Ruth Morgan, Gerard J Nuovo, Alison Merrick

Sci Transl Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
Alison E Merrick, Elizabeth J Ilett, Alan A Melcher

Curr Opin Investig Drugs· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma.
Robin J Prestwich, Karen J Scott, Joanne Brown, Patricia Harnden, Peter Whelan, Alison E Merrick

BJU Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery.
Emma West, Ruth Morgan, Karen Scott, Alison Merrick, Anatole Lubenko

J Immunother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.
Paul Hatfield, Alison E Merrick, Emma West, Dearbhaile O'Donnell, Peter Selby

J Immunother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OK432-activated human dendritic cells kill tumor cells via CD40/CD40 ligand interactions.
Katy S Hill, Fiona Errington, Lynette P Steele, Alison Merrick, Ruth Morgan

J Immunol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy.
Alison Merrick, Rosa Maria Diaz, Dearbhaile O'Donnell, Peter Selby, Richard Vile

Cancer Immunol Immunother· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killing.
Nikolaos T Georgopoulos, Alison Merrick, Nigel Scott, Peter J Selby, Alan Melcher

Int J Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
Fiona Errington, Andrew Bateman, Tim Kottke, Jill Thompson, Kevin Harrington, Alison Merrick

Clin Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis